Navigation Links
Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
Date:10/10/2007

SAN CARLOS, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that preclinical data for its proprietary product candidate NKTR-102 (PEG-irinotecan) will be presented at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Therapeutics in San Francisco, California on October 25, 2007. The presentations will highlight new results from preclinical trials of NKTR-102 in mouse models of colorectal, lung and breast cancers. NKTR-102 is a PEGylated form of irinotecan created using Nektar's innovative small molecule PEGylation technology platform and is in Phase 1 clinical development for the treatment of solid tumors.

In preclinical studies presented at ECCO 14 in September, NKTR-102 substantially suppressed tumor growth in an irinotecan-resistant mouse colorectal tumor model, while irinotecan-treated groups did not show a statistically significant decrease in tumor growth compared to controls. Further, administration of NKTR-102 resulted in a significantly improved pharmacokinetic profile for the active metabolite of irinotecan as compared to treatment with irinotecan.

"The studies for NKTR-102 continue to indicate that Nektar's small molecule PEGylation technology can be a powerful platform for improving chemotherapeutic agents," Tim Riley, Ph.D., Vice President of PEGylation Research at Nektar. "The new preclinical data in colorectal, lung and breast tumor models also highlights the promise of NKTR-102 to serve as a potentially new and powerful therapy in multiple solid tumor settings."

Two poster presentations are scheduled:

October 25, 2007 - 12:30 PM - 2:00 PM (PT); 5:30 - 7:30 PM (PT)

Poster Session C -- AACR-NCI-EORTC
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
2. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
3. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
4. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
5. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
7. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...IDGE, N.J., Nov. 25 Regado Bioscie...ment of antithrombotic aptamers with active contro... President, will be presenting at the Piper Jaffra...rk Palace Hotel in New York City. Dr. Mazzo,s pre..., December 1 and will include an overview of the C...
(Date:11/25/2009)...YORK, Nov. 25 Reportlinker.com ann...ble in its catalogue: ,, Mammography Equipmen...w.reportlinker.com/p0164330/Mammography-Equipment-...ncidence of breast cancer in industrialized as wel...uencing growth in the mammography market. Globally...
(Date:11/25/2009)...HAM, Mass., Nov. 25 According to M...ty on medical technology market intelligence, the ...vices will continue to see rapid growth over the n...n. MRG,s US Markets for Trauma Devices 2010 re...amic over the next five years, with competitors in...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Promising pharmaceutical agents emerge as sports doping products 61689 1Promising pharmaceutical agents emerge as sports doping products 61689 2Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve 61688 1Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve 61688 2Diet Delivery Company Bistro MD Is Giving Away 241 500 in First Ever Creative Writing Contest 61685 1Diet Delivery Company Bistro MD Is Giving Away 241 500 in First Ever Creative Writing Contest 61685 2Diet Delivery Company Bistro MD Is Giving Away 241 500 in First Ever Creative Writing Contest 61685 3
...cidic treatments benefit poultry .... 6 FreshFx Antimicrobial Solution,which is used ... identified,in an October 2007 Watt Poultry USA ar...ction dilemma." Citing recent studies in large-sc...iate Professor of Poultry Science Scott Russell, P...
...,Innovations, Inc. (Amex: IMA ), a leading manufa...or the consumer and professional markets, announce...th Annual Healthcare,Conference on November 7, 200...n Russell, Vice President of Finance, will attend....mber 7 at 10:20 a.m. The presentation is,not being...
Other Medicine Technology:FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma' 2
(Date:11/27/2009)...v. 27 The Gymboree Corpo...rt, CFO/COO, will present at the NASDAQ OMX 23rd I...r Hotel in London, England, on Wednesday, December...live broadcast of The Gymboree Corporation,s prese...mboree.com, click on "Our Company" at the bottom o...
(Date:11/27/2009)...naCare Holdings has announced that it has become a... of the largest nonprofit organizations dedicated ... , Delray Beach, FL (Vocu...TCBB: XCHO), a company specializing in the marketi...products, has announced today that is has become a...
(Date:11/27/2009)...yant Health™ announced today that Spectrum H...aumaCad Enterprise orthopedic templating solution ... (PRWEB) November 27, 2009 -- ... Health (Grand Rapids, Michigan) has licensed its ...n and its TraumaCad Extend workflow solution, to a...
(Date:11/26/2009)...7 With cold and flu season upon us...ctices to control the spread of infections and avo...y to keep ourselves healthy, but to avoid transmit...RN, MS, CIC (certified in infection-control), nurs...l health at Hospital for Special Surgery (HSS) in ...
(Date:11/26/2009)...o heavy can lead to strains or worse , ,...e nothing wrong with stuffing your turkey full to ...ing with your suitcase as you pack for holiday tri...008 in U.S. hospital emergency rooms, doctors, off...gage-related injuries, such as muscle strains, pul...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...re-FirstCall/ -- Viscorp Inc.,(OTC Bulletin Board:...nized,traditional Chinese medicine ("TCM") based i...ged its name to Tianyin Pharmaceutical, Co., Inc.,...ew CUSIP Number of 88630M 104., Viscorp and Rayge...
...ings,Inc. (OTC Bulletin Board: IFMX) is pleased to...ners to provide Capital Markets Advisory Services ...City, is a 16 year old firm,that specializes in pr... exchange listings, Sarbanes Oxley requirements,in...
...t,Services, Inc. (Nasdaq: BDMS ), operators of PE...ence call to review year-end and fourth quarter 20...-end results, the,teleconference may include discu...in to 1-866-837-9780; refer to Birner Dental Manag...
...ailable in Time for Spring Allergy ...N.C., March 11 A,special-edition Zagat Survey(R) ... and year-round allergies an insider,s view of the...e is,available at http://www.outandaboutwithaller...
... theme of this year,s conference;, learn about the...inciples, in the field of electromagnetic radiati...le who are creating healthy buildings every day, ... patient,s home be making them sick?" As a builder...
...rtified Organic, Low Fat, Rich and Creamy Bever...nt, FULLERTON, Calif., March 11 Wildwood Organic... provider of soy food,products, today launched Pro...ng. Probiotic Soymilk(TM) is also free from,satura...
Other Medicine News:Health News:Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker 'OTC BB: TYNP' 2Health News:InforMedix Retains Murdock Capital Partners 2Health News:InforMedix Retains Murdock Capital Partners 3Health News:InforMedix Retains Murdock Capital Partners 4Health News:20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips 2Health News:20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips 3Health News:2008 Building Biology(R) Conference, April 19th & 20th, Hotel Radisson at Opryland, Nashville, Tennessee 2Health News:2008 Building Biology(R) Conference, April 19th & 20th, Hotel Radisson at Opryland, Nashville, Tennessee 3Health News:Wildwood Organics Introduces Probiotic Soymilk(TM) 2
...ulation (ECP) is a surgical approach to glaucoma m...ized laser application. The ciliary body (which pr...rom the anterior or posterior segment, through the...sily and accurately identified utilizing endoscopy...
Moore Hyperopic Flap Conformer, 40 Diopter
Anis™ Suction Ring
Micro Knife, 45 Degree
Medicine Products: